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Aomputed tomography (CT) is one of the most rapidly
volving techniques for assessing cardiovascular anatomy.
he complex nature of the imaging devices and anatomy
s well as the rapidly advancing uses of these modalities
equires the trainee to be introduced to this modality.
linical application of CT encompasses non-contrast
coronary calcium evaluation), contrast (CT angiography
nd function), and hybrid studies (combining nuclear
ardiac scanning with CT). Computed tomography, like
nvasive catheterization, provides information concerning
ardiovascular anatomy and function (i.e., ejection frac-
ion). Hybrid devices are rapidly evolving to incorporate
tate-of-the-art, high-speed multi-detector computed to-
ography (MDCT) technology, along with the latest
ositron emission tomography, and single-photon emis-
ion computed tomography (SPECT) detector systems.
urrent hybrid systems (MDCT plus nuclear) provide
ttenuation correction for SPECT, thereby further im-
roving the diagnostic accuracy of more traditional ra-
ionuclide techniques.
It should be noted that the guidelines for fellows
n training outlined here and those for physicians in
ractice previously published have slightly different tar-
ets for time and experience. The fellows-in-training are
xpected to gain exposure to CT throughout their train-
ng, incorporating the results with echocardiography,
uclear cardiology, cardiovascular magnetic resonance
CMR), and cardiac catheterization when appropriate.
hysicians-in-practice who are being exposed to cardiac
T for the first time will most likely not have this
omprehensive approach. Guidelines for practicing phy-
icians are published by the American College of Cardi-
logy/American Heart Association Task Force on Clin-
cal Competence in CT and MR (1). Fellowship training
n CT should include instruction in the basic aspects, but
nly those fellows who go beyond the basic level are
rained sufficiently for independent interpretation of CT
tudies. Every trainee should be educated in the use of
T and in cardiovascular anatomy, physiology, and aathophysiology, as well as physics of CT and radiation
eneration and exposure. As many cardiovascular com-
uted tomographic (CCT) studies are done before and
fter intravenous administration of iodinated contrast, a
horough understanding of contrast injection methods,
dverse events and their treatments, and contrast kinetics
n patients will be required. In particular, knowledge is
eeded in the methods of contrast-enhanced imaging of
he pericardium, right ventricle, right atrium, and supe-
ior and inferior vena cavae, as well as imaging of the left
eart, surrounding great vessels, and the central
irculation.
By the end of the fellowship, trainees should have been
xposed to cardiac CT studies, both in interpretation and
erformance. It is currently recognized that many programs
ight not have availability of CCT, and options should be
ade available to obtain training at a different facility if the
rimary program cannot accommodate. The trainee should
aster the relation between the results of the CT examina-
ion and findings of other cardiovascular tests, such as
atheterization, nuclear cardiology, MR, and echocardiog-
aphy. Every cardiology fellow should be exposed to and be
amiliar with the technical performance, interpretation,
trengths, and limitations of CT and its multiple clinical
pplications. It is recognized that CT is an evolving tech-
ology in a rapid phase of development and improvement,
ith an expanding list of clinical indications.
For appropriate use of this technology, it is possible to
efine three levels of expertise (Table 1). All cardiology
ellows must attain at least the first level of expertise. This
ntails understanding the basic principles, indications, ap-
lications, and technical limitations of CT and the inter-
elation of this technique with other diagnostic methods.
his level will not qualify a trainee to perform CT or to
nterpret CT independently.
Level 2 is defined as the minimum recommended training
or a trainee to independently perform and interpret CCT.
third level of expertise would enable the trainee to direct
CT laboratory.
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he CT laboratory in which training is undertaken should
e under the direct supervision of a full-time qualified
irector (or directors) who has preferably achieved Level 3
raining. Training guidelines in the present document are
rimarily directed to trainees performing cardiac CT exam-
nations in adult patients with acquired and congenital heart
isease. Participation of additional full- or part-time faculty
s highly desirable because of the multiple applications of
T (i.e., attenuation correction of nuclear imaging, non-
ontrast and contrast studies, function, structure, and con-
enital). The cardiac CT examination is an operator-
ependent procedure in which it is possible to introduce
onfounding artifacts or omit data of diagnostic importance.
ands-on training is important, not to develop technical
xpertise in acquiring images but rather as a valuable aid to
earn tomographic cardiac anatomy, integrate planar views
nto a three-dimensional framework (non-planar and
blique/multiplanar imaging), and understand the distinc-
ion between reliable and unreliable data. Understanding
he source of the artifacts (breath-holding, gating, or ar-
hythmias) present on the images is vital.
ONTENT OF THE TRAINING PROGRAM
lthough the number of studies and time intervals of training
re given as guidelines, these numbers are less important
han the depth of understanding and quality of the clinical
xperience. It is recommended that fellows keep a log docu-
enting their involvement in CT studies, as well as their
xposure to appropriate continuing medical education hours.
The recommendations for all levels of training in the
ollowing text represent a cumulative experience, and it is
xpected that for many fellows the training will not be
ontinuous. A summary of the training requirements is
iven in Table 1. For all Level 2 and 3 requirements, the
inimum time in a CCT laboratory is 50% of the time
isted. The remaining time required can be garnered by
upervised time, CT exposure in courses, case studies,
D/DVD training, time at major medical meetings devoted
able 1. Requirements for CCT Study Performance and
nterpretation to Achieve Level 1, 2, and 3 Clinical Competence
Cumulative
Duration
of Training
Minimum Number
of Mentored
Examinations
Present During
Performance
Minimum Number
of Mentored
Examinations
Interpreted
evel 1 1 month* — 50†
evel 2 2 months* 35 150†
evel 3 6 months* 100 300†
This represents cumulative time spent interpreting, performing and learning about
CT, and need not be a consecutive block of time, but at least 50% of the time should
epresent supervised laboratory experience. In-lab training time is defined as a
inimum of 35 h/week. †The caseload recommendations may include studies from
n established teaching file, previous CCT cases, journals and/or textbook or
lectronic/on-line courses/continuing medical education.
CCT  cardiovascular computed tomography.o performance of CCT, or other relevant educational praining activities to name a few examples. The caseload
ecommendations may include studies from an established
eaching file, previous CCT cases, electronic/online experi-
nce, or courses.
evel 1 Training (1 Month,
t Least 50 Examinations Interpreted)
evel 1 is defined as the minimal introductory training for
amiliarity with CCT, but is not sufficient for independent
nterpretation of CCT images. The individual should have
ntensive exposure to the methods and the multiple appli-
ations of CCT for a period of at least 1 month. The time
ommitment for training is defined as 35 h/week. This
hould provide a basic background in CCT for the practice
f adult cardiology. During this cumulative 4-week experi-
nce, individuals should have been actively involved in CCT
nterpretation under the direction of a qualified (preferably
evel 3-trained) physician-mentor (1). There should be a
entored interpretative experience of at least 50 cases for all
tudies in which other cardiovascular imaging methods are
lso available as well as correlation with CCT findings and
nterpretation. Mentored interpretive experience may in-
lude studies from an established teaching file or previous
CT cases and also includes the potential for CD/DVD
nd online training.
For all levels of competence, it is expected that the
andidate will attend lectures on the basic concepts of CCT
nd include parallel self-study reading material. A basic
nderstanding of CCT should be achieved including: the
hysics of CCT imaging, the basics of CCT scan perfor-
ance, safety issues in CCT performance, side effects (and
heir treatment) of medications used currently including
eta-blockers and nitrates, post-processing methods, and
he basics of CCT interpretation as compared with other
ardiovascular imaging modalities including echocardiogra-
hy, nuclear cardiology, cardiac MR, and invasive cardiac
nd peripheral X-ray angiography. Furthermore, auxiliary
ardiac diagnostics should include recognition of ventricular
ypertrophy, dilation, valve pathologies such as mitral
tenosis/annular and leaflet calcification, aortic valve pathol-
gy (number of cusps), and calcification/aortic stenosis,
ericardial disease, internal mammary arteries, and saphe-
ous vein grafts.
evel 2 Training (2 Months of
raining and Interpretation of 50 Non-Contrast
nd 150 Contrast Studies Total, of Which in 35 the
ellow is Present During Performance)
evel 2 is defined as the minimum recommended training
or a physician to independently perform and interpret
CT. To accomplish this, the fellow should devote an
dditional 1 month, or the equivalent, interpreting a mini-
um of 150 contrast studies total. The non-contrast and
ontrast studies may be evaluated in the same patients. Of
hese, at least 35 cases should be performed with the fellow
resent under appropriate supervision. Competence at this
l
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February 21, 2006:915–20 Task Force 12: Training in Advanced Cardiovascular Imaging (CT)evel implies that the fellow is sufficiently experienced to
nterpret the CT examination accurately and independently.
ontinued exposure to special CT procedures such as
ybrid studies with nuclear imaging and integration of
mages into electrophysiologic procedures is appropriate
uring Level 2 training.
Didactic studies should include advanced-lecture reading
aterials and formal case presentations. These didactic
tudies should include information on the sensitivity, spec-
ficity, accuracy, utility, costs, advantages, and disadvantages
f CCT as compared with other cardiovascular imaging
odalities. Each fellow should receive documented training
rom a CCT mentor and/or physicist on the basic physics of
T in general and on CCT in particular. Lectures will
nclude discussions of anatomy, contrast administration and
inetics, and the principles of three-dimensional imaging
nd post-processing. The fellow should also receive training
n principles of radiation protection, the hazards of radiation
xposure to both patients and CT personnel, and appropri-
te post-procedure patient monitoring.
A fellow with Level 2 and Level 3 training should demon-
trate a clear understanding of the various types of CT
canners available for cardiovascular imaging (electron beam
omography and MDCT) and understand, at a minimum,
ommon issues related to imaging, post-processing, and
can interpretation including:
Indications and risk factors that might increase the
likelihood of adverse reactions to contrast media
Radiation exposure factors
CT scan collimation (slice thickness)
CT scan temporal resolution (scan time per slice)
Table speed (pitch)
Field of view
Window and level view settings
Algorithms used for reconstruction
Contrast media
Presence and cause of artifact
Post-processing techniques and image manipulation on
work stations
Total radiation dose to the patient
ncidental Non-Cardiac Findings
uring a cardiac CT examination, the standard use of a
mall field of view (e.g., limited lung fields) precludes a
omplete evaluation of the entire thorax. However, to
ddress the possibility that significant non-cardiac imaging
ndings (e.g., aortic disease, hilar adenopathy, large pulmo-
ary nodules, and pulmonary emboli) might be present on a
ardiac CT scan, specific interpretation of the extra-cardiac
elds should be performed. The patient and the referring
hysician should understand that the focus of the cardiac
T examination is the detection of cardiac disease, and the
can does not encompass the entire lung field. Regarding
he cardiovascular medicine specialist performing a cardiac
T, the American College of Cardiology recognizes and undorses education and training of such individuals in the
ecognition of incidental scan findings in support of quality
maging care of patients with cardiovascular disease. These
ases require referral to a specialist or a radiologist with
xpertise in chest imaging. To this end, it is felt that Level
and Level 3 training should include the review of all
ardiac CT cases for non-cardiac findings. The review of
50 cardiac CT cases for incidental findings should include
he review of a dedicated teaching file of 25 cardiac CT
ases featuring the presence of significant non-cardiac pa-
hology. Furthermore, part of the core curricula for Level 2
nd Level 3 should include specific lectures on non-cardiac
T pathology.
evel 3 Training (Total 12 Months
f Training, Inclusive of Level 1 and
evel 2, 150 Additional Examinations)
evel 3 training represents the highest level of exposure/
xpertise that would enable an individual to serve as a director
f an academic CCT section or director of an independent
CT facility or clinic. This individual would be directly
esponsible for quality control and training of technologists
nd be a mentor to other physicians seeking such training.
or a trainee desiring to direct a CT laboratory (Level 3), a
otal of 6 months of training devoted to CT is required, with
n additional 6 months’ experience that can be obtained
oncurrently with training in other imaging modalities. To
ttain Level 3, candidates should be involved with interpre-
ation of at least 100 non-contrast and 300 contrast CCT
xaminations. For at least 100 of these cases, the candidate
ust be physically present and be involved in the acquisition
nd interpretation of the case. At the discretion of the
irector, increasing independence in interpretation and
verreading of CT studies can be implemented.
In addition to the recommendations for Level 1 and
evel 2 training, Level 3 training should include active and
ngoing participation in a basic research laboratory, clinical
esearch, or graduate medical teaching. Level 3 training
hould also include exposure to administrative aspects of
unning a CT laboratory and documented experience in CT
esearch, as well as understanding of new and evolving
T and nuclear/CT technologies. To complete Level 3,
he trainee should fulfill all of the previously described
equirements and develop competence in performing and
nterpreting special procedures, such as hybrid studies and
lectrophysiologic studies (integration of CT images with
uoroscopic images to provide enhanced visualization for
blation).
raining for Physicians in Practice
t should be recognized how difficult it is to recreate the
readth and intensity of a training fellowship once an individ-
al has assumed the full-time responsibilities of a practice
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quivalent training, please refer to the recent report of the
merican College of Cardiology Foundation/American Heart
ssociation/American College of Physicians Task Force on
linical Competence on CT and MR (1).EFERENCE
. Budoff MJ, Cohen MC, Garcia M, et al. ACC/AHA clinical compe-
tence statement on cardiac imaging with computed tomography and
magnetic resonance. A report of the American College of Cardiology/
American Heart Association/American College of Physicians Taskdoi:10.1016/j.jacc.2005.12.030
Force on Clinical Competence (ACC/AHA Committee on Cardiac
Tomography). J Am Coll Cardiol 2005;46:383–402.
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